Shanghai RAAS donated over 8 million yuan in drugs and cash to Wuhan
In the face of the spread of pneumonia caused by COVID-19, Shanghai RAAS Blood Products Co., Ltd. actively deployed epidemic prevention and control, and rushed to rescue drug supplies everywhere.
On the morning of February 1st at 10 o'clock, Shanghai RAAS donated over 8 million yuan of drugs and cash, which were successfully delivered to Wuhan. This donation includes 3.08 million yuan worth of intravenous immunoglobulin drugs donated to 10 hospitals, including Tongji Hospital affiliated with Huazhong University of Science and Technology, Union Medical College affiliated with Tongji Medical College, and Hubei Provincial People's Hospital, as well as 5 million yuan in cash donated to the Jiang'an District Charity Association in Wuhan.
As a leading enterprise in the domestic blood product industry, Shanghai RAAS produces intravenous immunoglobulin, which is separated and purified from human plasma. The product contains broad-spectrum antibodies and has the functions of immune enhancement and prevention and treatment of viral infections. In the fight against COVID-19 pneumonia, local health committees and major hospitals have formulated prevention and control plans. In the guidance document issued by the Shanghai Municipal Health Commission, intravenous immunoglobulin is listed as an immune regulatory variety. Beijing Union Medical College Hospital also includes this product in its prevention and treatment plan and recommends its use for critically ill patients.
It is reported that during the Spring Festival, Shanghai RAAS organized employees to work overtime to carry out drug production and delivery work, and promptly sent intravenous immunoglobulins to the whole country. The company strives to accelerate production and release processes, actively stock up to meet the needs of the epidemic and patients, overcome the difficulties of tight logistics during the Spring Festival, and promptly send drugs and donations to epidemic areas and various medical institutions. With practical actions, the company fulfills its sacred mission of "people's cause, national sentiment", and works together with the people and medical workers in Wuhan.
At present, the battle against novel coronavirus pneumonia is in a critical period, and medical staff around the world are fighting on the front line, day and night; The aid efforts of various industries, fields, and enterprises have never stopped. As a compassionate and responsible enterprise, Shanghai Laishi will take practical actions to fulfill its responsibility in combating the epidemic.